CRY News and Press, CryoLife Inc. From 04/01/20

ATLANTA , April 1, 2020 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today it has taken multiple steps to focus on the health and welfare of its employees, patients, and customers. "...

ATLANTA , Feb. 27, 2020 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing resumed distribution in the European Union....

Curaleaf (CURA CN) initiated with Neutral rating and C$11.40 (41% upside) price target at Cantor Fitzgerald. U.S. ticker: ( OTCPK:CURLF ). More news on: Curaleaf Holdings, Inc., Pfenex Inc., Trulieve Cannabis Corp., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. CryoLife   (NYSE: CRY) Q4 2019 Earnings Call Feb 13, 2020 , 4:30 p.m. ET Operator Continue reading

CryoLife, Inc. (CRY) Q4 2019 Earnings Conference Call February 13, 2020, 04:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Pat MacKin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer David Sa...

CryoLife (NYSE: CRY ) Q4 results : More news on: CryoLife, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...

CryoLife (NYSE: CRY ): Q4 Non-GAAP EPS of $0.10 beats by $0.07 ; GAAP EPS of -$0.02. More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ATLANTA , Feb. 13, 2020 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Total revenues were $69.7 million in the fourth quarter of 2019, reflecting year over year growth of 3% and a 4% increase on a non-GAAP constant currency basis, both compared to the fou...

ATLANTA , Jan. 30, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on Thursday, February 13, 2020 after the marke...

ATLANTA , Dec. 23, 2019 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received authorization from the U.S. Food and Drug Administration (FDA) pursuant to an Investigational New Drug ...